Tag: Drug-induced parkinsonism


PSEUDOPARKINSONISM

Pseudoparkinsonism: A Review Abstract Pseudoparkinsonism is a neurological disorder characterized by the presence of parkinsonian-like symptoms, such as bradykinesia, rigidity, and tremor, without any evidence of degeneration of the dopaminergic pathways in the brain. This disorder occurs as a result of various medications and medical conditions that interfere with normal central nervous system functioning. In […]

Read More

TRIHEXYPHENIDYL

Introduction and Definition Trihexyphenidyl, often referred to by the trade name Artane, is a potent synthetic anticholinergic drug classified chemically as a piperidine derivative. This medication acts centrally within the nervous system and is primarily utilized for the remediation and management of motor symptoms associated with movement disorders. Specifically, it is employed to mitigate drug-induced […]

Read More

EXTRAPYRAMIDAL EFFECTS

Defining Extrapyramidal Effects and the Associated Tract Extrapyramidal Effects (EPEs) serve as an umbrella term encompassing a constellation of reactions and side effects that specifically involve the neural pathways of the extrapyramidal tract within the central nervous system. These effects manifest primarily as movement disorders, characterized by disturbances in muscle tone, posture, and motor control […]

Read More

ANTIPARKINSONIAN AGENTS

Definition and Scope of Antiparkinsonian Agents Antiparkinsonian agents are a diverse group of pharmacological compounds specifically utilized to mitigate the debilitating motor and non-motor symptoms associated with Parkinson’s disease (PD) and related parkinsonian syndromes. The primary goal of these medications is to restore functional balance within the basal ganglia, counteracting the profound depletion of dopamine […]

Read More